Info Obat dan Regulator Obat Dunia

F
Benefit-Risk Assessment for New Drug and Biological Products
Replies
0
Views
203
FDA
F
F
FDA Roundup: October 17, 2023
Replies
0
Views
226
FDA
F
F
A Joint US-FDA | MHRA-UK | Health Canada Good Clinical Practice & Pharmacovigilance Compliance Workshop - 02/13/2024
Replies
0
Views
222
FDA
F
F
Covalon Technologies Inc. - 614350 - 05/06/2021
Replies
0
Views
222
FDA
F
F
FDA approves nivolumab for adjuvant treatment of Stage IIB/C melanoma
Replies
0
Views
253
FDA
F
F
Allure Imports - 613211 - 04/07/2021
Replies
0
Views
207
FDA
F
F
Crown Wellness, Inc - 610844 - 04/29/2021
Replies
0
Views
229
FDA
F
F
About Mineral - 613984 - 04/07/2021
Replies
0
Views
205
FDA
F
F
BGP, LLC - 613144 - 05/19/2021
Replies
0
Views
217
FDA
F
F
FDA approves neoadjuvant/ adjuvant pembrolizumab for resectable non-small cell lung cancer
Replies
0
Views
246
FDA
F
F
Disinfect & Shield - 613716 - 05/06/2021
Replies
0
Views
217
FDA
F
E
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 October 2023, CHMP, 13/10/2023
Replies
0
Views
244
EMA
E
E
New treatment option for heavily pre-treated multiple myeloma patients , CHMP, 13/10/2023
Replies
0
Views
270
EMA
E
F
FDA Clinical Investigator Training Course (CITC) 2023 - 12/06/2023
Replies
0
Views
216
FDA
F
F
FDA Roundup: October 13, 2023
Replies
0
Views
232
FDA
F
F
Psychopharmacologic Drugs Advisory Committee Charter
Replies
0
Views
249
FDA
F
F
Advancing the Development of Pediatric Therapeutics (ADEPT) 8 Workshop on Drug Dosing in Pediatric with Renal Impairment - 11/30/2023
Replies
0
Views
213
FDA
F
F
Drug Trials Snapshots: ENJAYMO
Replies
0
Views
229
FDA
F
F
BsUFA III Regulatory Science Pilot Program - 10/16/2023
Replies
0
Views
210
FDA
F
F
Quality Considerations for Topical Ophthalmic Drug Products
Replies
0
Views
207
FDA
F
You must log in or register to post here.
Top